Gsk (GSK) Retained Earnings (2009 - 2026)
Gsk (GSK) posted Retained Earnings of $1.8 billion for Q4 2025, down 82.44% on a QoQ basis from $10.0 billion in Q4 2024, and down 82.44% year-over-year from $10.0 billion in Q4 2024.
Gsk (GSK) has 11 years of Retained Earnings data on file, last reported at $1.8 billion in Q4 2025.
- In Q4 2025, Retained Earnings fell 82.44% year-over-year to $1.8 billion; the TTM figure through Dec 2025 stood at $1.8 billion (down 82.44% YoY), while the FY2025 annual figure was $1.8 billion, down 82.44% from the prior year.
- Retained Earnings retreated to $1.8 billion in Q4 2025, from $10.0 billion in the prior quarter.
- Across five years, Retained Earnings topped out at $10.0 billion in Q4 2024 and bottomed at $516.3 million in Q4 2021.
- A 5-year average of $3.3 billion and a median of $1.8 billion in 2025 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2024 — Retained Earnings soared 278.68% — and 2025, when it slumped 82.44%.
- Year by year, Retained Earnings stood at $516.3 million in 2021, then surged by 228.96% to $1.7 billion in 2022, then soared by 55.58% to $2.6 billion in 2023, then soared by 278.68% to $10.0 billion in 2024, then sank by 82.44% to $1.8 billion in 2025.
- The last three Retained Earnings figures came in at $1.8 billion (Q4 2025), $10.0 billion (Q4 2024), and $2.6 billion (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 29.51 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | -14.83 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | -17.87 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 66.72 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | -190.00 Mn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 78.00 Mn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | -7.20 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | -1.37 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 1.76 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.63 Bn |
| Dec 31, 2025 | 13.58 Bn |
| Sep 30, 2025 | 13.52 Bn |
| Jun 30, 2025 | 11.74 Bn |
| Mar 31, 2025 | 10.46 Bn |
| Dec 31, 2024 | 10.01 Bn |
| Sep 30, 2024 | 10.64 Bn |
| Jun 30, 2024 | 10.83 Bn |
| Mar 31, 2024 | 10.07 Bn |
| Dec 31, 2023 | 2.64 Bn |
| Sep 30, 2023 | 8.89 Bn |
| Jun 30, 2023 | 8.03 Bn |
| Mar 31, 2023 | 6.87 Bn |
| Dec 31, 2022 | 1.70 Bn |
| Sep 30, 2022 | 3.05 Bn |
| Jun 30, 2022 | 12.37 Bn |
| Mar 31, 2022 | 12.93 Bn |
| Dec 31, 2021 | 516.29 Mn |
| Sep 30, 2021 | 10.73 Bn |
| Jun 30, 2021 | 10.31 Bn |
| Mar 31, 2021 | 9.24 Bn |
| Dec 31, 2020 | 1.72 Bn |
| Jun 30, 2020 | 8.22 Bn |
| Mar 31, 2020 | 8.14 Bn |
| Dec 31, 2019 | 3.03 Bn |
| Sep 30, 2019 | 6.49 Bn |
| Jun 30, 2019 | -3.61 Bn |
| Mar 31, 2019 | -3.17 Bn |
| Dec 31, 2018 | 2.65 Bn |
| Sep 30, 2018 | -2.71 Bn |
| Jun 30, 2018 | -3.65 Bn |
| Mar 31, 2018 | -8.84 Bn |
| Dec 31, 2017 | 2.34 Bn |
| Sep 30, 2017 | -7.00 Bn |
| Jun 30, 2017 | -7.48 Bn |
| Mar 31, 2017 | -6.08 Bn |
| Dec 31, 2016 | 2.76 Bn |
| Sep 30, 2016 | -8.61 Bn |
| Jun 30, 2016 | -8.73 Bn |
| Mar 31, 2016 | -5.30 Bn |
| Dec 31, 2015 | 3.55 Bn |
| Sep 30, 2015 | -1.05 Bn |
| Jun 30, 2015 | 851.02 Mn |
| Mar 31, 2015 | 1.68 Bn |
| Dec 31, 2014 | 3.55 Bn |
| Sep 30, 2014 | -1.99 Bn |
| Jun 30, 2014 | -265.86 Mn |
| Mar 31, 2014 | 791.00 Mn |
| Dec 31, 2013 | 1.48 Bn |
| Sep 30, 2013 | -199.95 Mn |
| Jun 30, 2013 | 635.82 Mn |
| Mar 31, 2013 | 2.01 Bn |
| Dec 31, 2012 | 1.03 Bn |
| Sep 30, 2012 | 1.67 Bn |
| Jun 30, 2012 | 3.23 Bn |
| Mar 31, 2012 | 6.20 Bn |
| Dec 31, 2011 | 5.30 Bn |
| Sep 30, 2011 | 5.07 Bn |
| Jun 30, 2011 | 7.35 Bn |
| Mar 31, 2011 | 7.98 Bn |
| Dec 31, 2010 | 7.55 Bn |
| Sep 30, 2010 | 9.05 Bn |
| Jun 30, 2010 | 7.33 Bn |
| Mar 31, 2010 | 10.65 Bn |
| Dec 31, 2009 | 10.33 Bn |
| Sep 30, 2009 | 9.35 Bn |
| Jun 30, 2009 | 6.59 Bn |
| Mar 31, 2009 | 6.64 Bn |